Wnt/β-Catenin Inhibition by CWP232291 as a Novel Therapeutic Strategy in Ovarian Cancer

Wnt/β-Catenin Inhibition by CWP232291 as a Novel Therapeutic Strategy in Ovarian Cancer

The poor prognosis of ovarian cancer patients mainly results from a lack of early diagnosis approaches and a high rate of relapse. Only a very modest improvement has been made in ovarian cancer patient survival with traditional treatments. More targeted therapies precisely matching each patient are...

Full description

Bibliographic Details
Main Authors: Wenyu Wang, Untack Cho, Anna Yoo, Chae-Lim Jung, Boyun Kim, Heeyeon Kim, Juwon Lee, HyunA Jo, Youngjin Han, Myoung-Hyun Song, Ja-Oh Lee, Se Ik Kim, Maria Lee, Ja-Lok Ku, Cheol Lee, Yong Sang Song
Format: Article
Language:English
Published: Frontiers Media S.A. 2022-05-01
Series:Frontiers in Oncology
Subjects:
Wnt/β-catenin
CWP232291
targeted therapy
organoids
ovarian cancer
Online Access:https://www.frontiersin.org/articles/10.3389/fonc.2022.852260/full

Internet

https://www.frontiersin.org/articles/10.3389/fonc.2022.852260/full

Similar Items